loading

Autolus Therapeutics Plc Adr Stock (AUTL) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-30
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Research and Development
21.91%
30.67
25.16 32.32 33.23 27.39
Interest Income/Expense
36.04%
19.27
30.13 5.014 5.02 4.905
Operating Income/Loss
5.21%
-38.76
-40.89 -42.91 -44.38 -39.15
Nonoperating Income/Loss
41.73%
-13.94
-23.92 -2.965 -1.135 -0.677
Income/Loss From Continuing Operations Before Tax
18.69%
-52.70
-64.81 -45.87 -45.51 -39.83
Income Tax Expense/Benefit
100.06%
-0.008
12.36 -0.021 0.04 -0.014
Income/Loss From Continuing Operations After Tax
31.72%
-52.69
-77.17 -45.85 -45.55 -39.81
Net Income/Loss
31.72%
-52.69
-77.17 -45.85 -45.55 -39.81
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
433.32K%
222.17
0.0513 173.98 173.86 173.83
Diluted Average Shares
433.32K%
222.17
0.0513 173.98 173.86 173.83
Basic Earnings Per Share
46.67%
-0.24
-0.45 -0.26 -0.26 -0.23
Diluted Earnings Per Share
46.67%
-0.24
-0.45 -0.26 -0.26 -0.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):